Calidi Biotherapeutics announced a public offering in San Diego on August 22, 2025, which was subsequently declared effective by the SEC.
1 report, 1 independent
Updated Aug 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Calidi Biotherapeutics announced a public offering in San Diego on August 22, 2025, which was subsequently declared effective by the SEC.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Calidi Biotherapeutics appointed Eric Poma as CEO and held an investor webinar via RedChip on July 22, 2025.Sub-event
- Ladenburg Thalmann and Laidlaw & Company co-manage a public offering for Calidi Biotherapeutics.Sub-event
Calidi Biotherapeutics announced a public offering in San Diego, declared effective by the SEC.1 source
Keep exploring
The entities involved
-
San Diego
seat of San Diego County, California, United States; second-largest city in California
-
Securities and Exchange Commission (Bangladesh)
government regulatory body overseeing the stock market
Related events
Coverage
Newest first; wire copies grouped- GlobeNewswireCalidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biot